| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.gianpathlabs.com | |
| Market Cap | 26.73 Cr. | |
| Enterprise Value(EV) | 25.23 Cr. | 2021-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 4.23 | Trailing Twelve Months Ending 2022-03 |
| Price-Earning Ratio (PE) | 6.11 | Trailing Twelve Months Ending 2022-03 |
| Industry PE | 50.40 | Trailing Twelve Months Ending 2022-03 |
| Book Value / Share | 17.62 | Trailing Twelve Months Ending 2022-03 |
| Price to Book Value | 1.47 | Calculated using Price: 25.85 |
| Dividend Yield | 0.00 | Period Ending 2021-03 |
| No. of Shares Subscribed | 1.03 Cr. | 10,341,527 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The company is engaged in the business of providing diagnostic and related healthcare services. The company provides a wide range of diagnostic tests and services like patient diagnosis services, prevention, and wellness diagnosis services to patients and healthcare providers. The company caters to individual patients, hospitals, corporates and other healthcare providers. The company offers various tests including biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology, and radiology services. | ||
| 1 Day |
|
|
| 1 Week |
|
+3.40% |
| 1 Month |
|
-15.25% |
| 3 Month |
|
-13.11% |
| 6 Month |
|
-36.41% |
| 1 Year |
|
-51.60% |
| 2 Year |
|
+133.09% |
| 5 Year |
|
|
| 10 Year |
|
| 3 years | 2019-03 | 2020-03 | 2021-03 | |
| Return on Equity (%) | 90.94 | 29.34 | 23.33 | |
| Return on Capital Employed (%) | 12.26 | 42.76 | 35.91 | |
| Return on Assets (%) | 1.28 | 11.16 | 14.49 |
| Particulars | 3 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Shh. Funds | 0 | 8 | 10 | |
| Non Curr. Liab. | 1 | 1 | 1 | |
| Curr. Liab. | 7 | 4 | 5 | |
| Minority Int. | ||||
| Equity & Liab. | 8 | 12 | 15 | |
| Non Curr. Assets | 4 | 8 | 9 | |
| Curr. Assets | 3 | 4 | 6 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 8 | 12 | 15 |
| Particulars | 3 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Net Sales | 1 | 8 | 10 | |
| Other Income | 0 | 0 | ||
| Total Income | 1 | 8 | 11 | |
| Total Expenditure | 0 | -5 | -7 | |
| PBIDT | 0 | 2 | 4 | |
| Interest | 0 | -1 | -1 | |
| Depreciation | 0 | 0 | 0 | |
| Taxation | 0 | 0 | -1 | |
| Exceptional Items | ||||
| PAT | 0 | 1 | 2 | |
| Adjusted EPS | 0 | 1 | 2 |
| Particulars | 3 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Cash Fr. Operatn. | 3 | 2 | 3 | |
| Cash Fr. Inv. | -3 | -4 | -1 | |
| Cash Fr. Finan. | 1 | 3 | 0 | |
| Net Change | 1 | 0 | 1 | |
| Cash & Cash Eqvt | 1 | 1 | 3 |
|
Sat, 01 Oct 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM Dear Sir Please find enclosed herewith a copy of proceedings of the 4th Annual General Meeting of the Company held on Friday September 30 2022.This is for your reference and record.Yours faithfully For Gian Life Care Limited |
|
Sat, 01 Oct 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM Please find enclosed herewith correct copy of proceedings of the 4th Annual General Meeting of the Company held on Friday September 30 2022. Kindly ignore the previous outcome due to some typographical error.This is for your reference and recordYours faithfully For Gian Life Care Limited |
|
Sat, 01 Oct 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report The 4th Annual General Meeting ("AGM") of Gian Life Care Limited was held on Friday 30th September 2022 at 09:30 A.M at the Registered Office of the company.The consolidated report of the Scrutinizer on remote e-voting prior and during the 4th Annual General Meeting of the company is attached herewith along with voting results.Please take the same on record.Thanking You For Gian Life Care Limited |
| Tue, 04 Oct 2022 |
High Delivery Percentage
|
Close Crossing Last Month Close From Below
|
Opening at High
|
Closing Above Previous High
|
High Decrease 1 Month
|
Equities
M.F.
Sectors